Literature DB >> 22093482

Estrogen receptor dependent gene expression by osteoblasts - direct, indirect, circumspect, and speculative effects.

Michael Centrella1, Thomas L McCarthy.   

Abstract

Hormone activated estrogen receptors (ERs) have long been appreciated as potent mediators of gene expression in female reproductive tissues. These highly targeted responses likely evolved from more elemental roles in lower organisms, in agreement with their widespread effects in the cardiovascular, immunological, central nervous, and skeletal tissue systems. Still, despite intense investigation, the multiple and often perplexing roles of ERs retain significant attention. In the skeleton, this in part derives from apparently opposing effects by ER agonists on bone growth versus bone remodeling, and in younger versus older individuals. The complexity associated with ER activation can also derive from their interactions with other hormone and growth factor systems, and their direct and indirect effects on gene expression. We propose that part of this complexity results from essential interactions between ERs and other transcription factors, each with their own biochemical and molecular intricacies. Solving some of the many questions that persist may help to achieve better, or better directed, use of agents that can drive ER activation in focused and possibly tissue restricted ways.
Copyright © 2011 Elsevier Inc. All rights reserved.

Mesh:

Substances:

Year:  2011        PMID: 22093482     DOI: 10.1016/j.steroids.2011.10.016

Source DB:  PubMed          Journal:  Steroids        ISSN: 0039-128X            Impact factor:   2.668


  8 in total

1.  A synergistic interaction of 17-β-estradiol with specific cannabinoid receptor type 2 antagonist/inverse agonist on proliferation activity in primary human osteoblasts.

Authors:  Marko Hojnik; Luka Dobovišek; Željko Knez; Polonca Ferk
Journal:  Biomed Rep       Date:  2015-05-26

2.  Phytoestrogens by inhibiting the non-classical oestrogen receptor, overcome the adverse effect of bisphenol A on hFOB 1.19 cells.

Authors:  Zar Chi Thent; Gabriele Ruth Anisah Froemming; Aletza Binti Mohd Ismail; Syed Baharom Syed Ahmad Fuad; Suhaila Muid
Journal:  Iran J Basic Med Sci       Date:  2020-09       Impact factor: 2.699

3.  Estradiol and Follicle-Stimulating Hormone as Predictors of Onset of Menopause Transition-Related Bone Loss in Pre- and Perimenopausal Women.

Authors:  Albert Shieh; Gail A Greendale; Jane A Cauley; Carrie Karvonen-Gutierrez; Carolyn J Crandall; Arun S Karlamangla
Journal:  J Bone Miner Res       Date:  2019-10-24       Impact factor: 6.390

4.  ERβ compensates for the absence of ERα function to promote osteoblast viability by inhibition of SOST signaling.

Authors:  Shijin Lu; Changying Sun; Congxiu Miao; Zhongfu Zhao
Journal:  Exp Ther Med       Date:  2017-08-24       Impact factor: 2.447

5.  Sphingosine-1-Phosphate Modulates the Effect of Estrogen in Human Osteoblasts.

Authors:  Duangrat Tantikanlayaporn; Irina L Tourkova; Quitterie Larrouture; Jianhua Luo; Pawinee Piyachaturawat; Michelle R Witt; Harry C Blair; Lisa J Robinson
Journal:  JBMR Plus       Date:  2018-01-29

6.  Gene promoter polymorphism of RUNX2 and risk of osteoporosis in postmenopausal Indonesian women.

Authors:  Elza I Auerkari; Dwi A Suryandari; Sri S Umami; Lindawati S Kusdhany; Tut Wuri A Siregar; Tri Budi W Rahardjo; Christopher Talbot; Eef Hogervorst
Journal:  SAGE Open Med       Date:  2014-04-13

7.  Temporal expression of Pelp1 during proliferation and osteogenic differentiation of rat bone marrow mesenchymal stem cells.

Authors:  Jing Wang; Zhu Qiang; Qiang Zhu; Shujun Song; Liang Shi; Chuanchuan Ma; Xiaoqing Tan; Ding Yin; Yin Ding; Zhongying Niu
Journal:  PLoS One       Date:  2013-10-16       Impact factor: 3.240

Review 8.  Effects of estrogens and estrogenic disrupting compounds on fish mineralized tissues.

Authors:  Patricia I S Pinto; Maria D Estêvão; Deborah M Power
Journal:  Mar Drugs       Date:  2014-08-15       Impact factor: 5.118

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.